Mayo Clinic released a video featuring Dr. Ricky Ashby and a prostate cancer survivor discussing how the disease is detected and diagnosed [1].
The initiative aims to bridge gaps in healthcare communication by targeting community members who may be at higher risk for the disease. Because prostate cancer often develops without noticeable symptoms, early detection is critical for successful treatment outcomes.
This discussion is part of the Prostate Cancer Conversation series, a partnership between the Mayo Clinic and Omega Psi Phi Fraternity, Inc. [1]. The collaboration focuses on empowering men to make informed decisions regarding screening and the diagnostic process.
Dr. Ashby and the survivor explain the various methods used to identify the presence of cancer in the prostate. The conversation emphasizes the importance of proactive health management, and the role of medical professionals in guiding patients through screening options [1].
By partnering with a historic fraternity, the clinic seeks to reach a broader demographic and reduce the stigma associated with prostate examinations. The series encourages men to discuss their family history and risk factors with their doctors to determine the best timing for initial screenings [1].
“Prostate cancer often develops without noticeable symptoms.”
This partnership represents a targeted public health strategy to increase screening rates among Black men, who statistically face higher risks of prostate cancer. By leveraging the trust and network of Omega Psi Phi Fraternity, Inc., Mayo Clinic is moving beyond clinical settings to address cultural barriers and systemic gaps in preventative care.
